Business
Block Listing - Six Monthly Review
Block Listing - Six Monthly Review.
About this update from Hikma Pharmaceuticals Plc
[{"type":"text","content":"\n \n\n\n\n+-------------------------------------------------------------------+\n| Name of Company: | Hikma Pharmaceuticals |\n| | PLC |\n|-----------------------------------------+-------------------------|\n| Name of scheme: | Hikma Pharmaceuticals |\n| | PLC 2004 Stock Option |\n| | Plan |\n|-----------------------------------------+-------------------------|\n| Period of return: | 6 October 2007 |\n| From: | To: 11 April 2008 |\n|-----------------------------------------+-------------------------|\n| Balance under block scheme: | 1,405,400 ordinary |\n| | shares of 10 pence each |\n|-----------------------------------------+-------------------------|\n| The amount by which the block scheme | 2,432,400 ordinary |\n| has been increased, if the scheme has | shares of 10 pence |\n| been increased since the date of the | |\n| last return: | |\n|-----------------------------------------+-------------------------|\n| Number of securities issued/allotted | 1,856,200 ordinary |\n| under scheme during period: | shares of 10 pence each |\n|-----------------------------------------+-------------------------|\n| Balance under scheme not yet issued/ | 1,981,600 ordinary |\n| allotted at end of period | shares of 10 pence each |\n|-----------------------------------------+-------------------------|\n| Number and class of securities | 166,537,951 ordinary |\n| originally listed and the date of | shares of 10 pence each |\n| admission | originally listed on 1 |\n| | November 2005 |\n|-----------------------------------------+-------------------------|\n| Total number of securities in issue at | 188,307,607 ordinary |\n| the end of the period | shares of 10 pence each |\n+-------------------------------------------------------------------+\n\n\n\n - ENDS -\n\nEnquiries:\n\nHikma Pharmaceuticals PLC +44 20 7399 2760\nHenry Knowles, Company Secretary\nSusan Ringdal, Investor Relations Director\n\nNotes to Editors\n\nAbout Hikma\n\nHikma Pharmaceuticals PLC is a fast growing multinational group\nfocused on developing, manufacturing and marketing a broad range of\nboth branded and non-branded generic and in-licensed pharmaceutical\nproducts. Hikma's operations are conducted through three businesses:\n\"Branded\", \"Injectables\" and \"Generics\". Hikma's operations are based\nprincipally in the Middle East and North Africa (\"MENA\") region,\nwh...